Cargando…
The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial
BACKGROUND: A dietary supplement containing a blend of 170 mg of N-oleyl-phosphatidylethanolamine (NOPE) and 100 mg of epigallocatechin-3-gallate (EGCG) has been shown to improve compliance to low caloric diets. Considering the cost of dietary ingredients, many manufacturers attempt to determine the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490828/ https://www.ncbi.nlm.nih.gov/pubmed/23033919 http://dx.doi.org/10.1186/1476-511X-11-127 |
_version_ | 1782248882223185920 |
---|---|
author | Mangine, Gerald T Gonzalez, Adam M Wells, Adam J McCormack, William P Fragala, Maren S Stout, Jeffrey R Hoffman, Jay R |
author_facet | Mangine, Gerald T Gonzalez, Adam M Wells, Adam J McCormack, William P Fragala, Maren S Stout, Jeffrey R Hoffman, Jay R |
author_sort | Mangine, Gerald T |
collection | PubMed |
description | BACKGROUND: A dietary supplement containing a blend of 170 mg of N-oleyl-phosphatidylethanolamine (NOPE) and 100 mg of epigallocatechin-3-gallate (EGCG) has been shown to improve compliance to low caloric diets. Considering the cost of dietary ingredients, many manufacturers attempt to determine the lowest efficacious dose. Thus, the purpose of this study was to evaluate the efficacy of 8-weeks of supplementation with a daily intake of 120 mg of NOPE and 105 mg of EGCG in conjunction with a low caloric diet and regular, moderate exercise on dietary compliance in healthy, overweight adults. An additional purpose was to examine the effect of this supplement/diet/exercise paradigm on changes in body composition, sensation of appetite, mood and severity of binge eating. METHODS: Fifty healthy, overweight (BMI > 25 m·kg(2)) men (15) and women (35) (SUP; n = 25; 32.7 ± 13.75 y; BMI = 33.4 ± 6.2; PLA; n = 25, 34.3 ± 12.7 years; BMI = 33.2 ± 6.8) were recruited for a double-blind, placebo controlled study. Each volunteer was randomly assigned to either the supplement (SUP; n = 25) or placebo group (PLA; n = 25). Based upon a self-reported 3-day dietary recall all volunteers were recommended a 500 kcal or 30% (maximum of 1000 kcal) reduction in caloric intake. Volunteers were also encouraged to exercise 30 minutes per day, three times per week. RESULTS: Subjects in SUP were significantly more compliant (x(2) = 3.86, p = 0.049) in maintaining a low caloric diet at week 4, but this was not able to be maintained through the 8-week study. In addition, a significant difference in mood, feelings of fatigue and confusion were noted between the groups at week 4, but again not maintained by week 8 where only feelings of tension were improved. No differences between groups (p > 0.05) were observed for body mass, body composition, feelings of hunger, and binge eating after eight weeks. CONCLUSION: Supplementing with a combination of 120 mg of NOPE and 105 mg of EGCG does appear to enhance compliance to a low caloric diet and improve mood for 4 –weeks, but loses its effectiveness by week 8. |
format | Online Article Text |
id | pubmed-3490828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34908282012-11-07 The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial Mangine, Gerald T Gonzalez, Adam M Wells, Adam J McCormack, William P Fragala, Maren S Stout, Jeffrey R Hoffman, Jay R Lipids Health Dis Research BACKGROUND: A dietary supplement containing a blend of 170 mg of N-oleyl-phosphatidylethanolamine (NOPE) and 100 mg of epigallocatechin-3-gallate (EGCG) has been shown to improve compliance to low caloric diets. Considering the cost of dietary ingredients, many manufacturers attempt to determine the lowest efficacious dose. Thus, the purpose of this study was to evaluate the efficacy of 8-weeks of supplementation with a daily intake of 120 mg of NOPE and 105 mg of EGCG in conjunction with a low caloric diet and regular, moderate exercise on dietary compliance in healthy, overweight adults. An additional purpose was to examine the effect of this supplement/diet/exercise paradigm on changes in body composition, sensation of appetite, mood and severity of binge eating. METHODS: Fifty healthy, overweight (BMI > 25 m·kg(2)) men (15) and women (35) (SUP; n = 25; 32.7 ± 13.75 y; BMI = 33.4 ± 6.2; PLA; n = 25, 34.3 ± 12.7 years; BMI = 33.2 ± 6.8) were recruited for a double-blind, placebo controlled study. Each volunteer was randomly assigned to either the supplement (SUP; n = 25) or placebo group (PLA; n = 25). Based upon a self-reported 3-day dietary recall all volunteers were recommended a 500 kcal or 30% (maximum of 1000 kcal) reduction in caloric intake. Volunteers were also encouraged to exercise 30 minutes per day, three times per week. RESULTS: Subjects in SUP were significantly more compliant (x(2) = 3.86, p = 0.049) in maintaining a low caloric diet at week 4, but this was not able to be maintained through the 8-week study. In addition, a significant difference in mood, feelings of fatigue and confusion were noted between the groups at week 4, but again not maintained by week 8 where only feelings of tension were improved. No differences between groups (p > 0.05) were observed for body mass, body composition, feelings of hunger, and binge eating after eight weeks. CONCLUSION: Supplementing with a combination of 120 mg of NOPE and 105 mg of EGCG does appear to enhance compliance to a low caloric diet and improve mood for 4 –weeks, but loses its effectiveness by week 8. BioMed Central 2012-10-04 /pmc/articles/PMC3490828/ /pubmed/23033919 http://dx.doi.org/10.1186/1476-511X-11-127 Text en Copyright ©2012 Mangine et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Mangine, Gerald T Gonzalez, Adam M Wells, Adam J McCormack, William P Fragala, Maren S Stout, Jeffrey R Hoffman, Jay R The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial |
title | The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial |
title_full | The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial |
title_fullStr | The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial |
title_full_unstemmed | The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial |
title_short | The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial |
title_sort | effect of a dietary supplement (n-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: a double-blind, randomized control trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490828/ https://www.ncbi.nlm.nih.gov/pubmed/23033919 http://dx.doi.org/10.1186/1476-511X-11-127 |
work_keys_str_mv | AT manginegeraldt theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT gonzalezadamm theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT wellsadamj theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT mccormackwilliamp theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT fragalamarens theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT stoutjeffreyr theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT hoffmanjayr theeffectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT manginegeraldt effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT gonzalezadamm effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT wellsadamj effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT mccormackwilliamp effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT fragalamarens effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT stoutjeffreyr effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial AT hoffmanjayr effectofadietarysupplementnoleylphosphatidylethanolamineandepigallocatechingallateondietarycomplianceandbodyfatlossinadultswhoareoverweightadoubleblindrandomizedcontroltrial |